Beginning in 1998, consensus conferences concerning the grading of urothelial cancer addressed removal of the word "carcinoma" from low-grade papillary tumors with little or no malignant potential. The subsequent change in terminology has been controversial, however, and many pathologists as well as most urologists continue to use the traditional three-grade classification system.
Cleveland-Which approach to radical nephrectomy produces the most durable outcomes in survival and restored renal function: laparoscopy or open surgery?
National Report-With another year of Medicare payment cuts looming in 2007, declining reimbursement is no surprise as the number one current concern among practicing urologists, according to an exclusive survey from Urology Times and its sister publication, Contemporary Urology. Changes in reimbursement are followed closely by malpractice, office overhead, pay for performance, and increasing regulations as the top five issues that urologists are extremely or very concerned about, the first State of the Specialty survey found.
Ankara, Turkey-Elevated PSA levels and the presence of urinary tract infection are the symptomatic parameters that are most predictive of acute urine retention in men with BPH, according to a group of Turkish researchers. Their data also suggest that plasmakinetic resection of the prostate may provide 1-year outcomes similar to those of open prostatectomy in BPH patients who do not have retention.
Cleveland-Understaging of renal tumors on the basis of clinical criteria appears problematic when tumors are morcellated during laparoscopic nephrectomy, according to a Mayo Clinic study presented at the 2006 World Congress of Endourology here.
We must increase the number of, and accrual to, clinical trials. The best way is in the setting of multidisciplinary clinics.
Men with overactive bladder and lower urinary tract symptoms who receive combination therapy are more likely to report improvement in symptoms than those who receive only one medication, according to results of a study recently reported in JAMA (2006; 296:2319-28).
The FDA has granted approval to two generic versions of extended-release oxybutynin chloride for the treatment of overactive bladder.
Three new staff members have joined the Cleveland Clinic Glickman Urological Institute: Jeffrey Palmer, MD, is the director of minimally invasive surgery, pediatric urology; Courtenay K. Moore, MD, is a specialist in female urology; and Edmund Sabanegh, MD, is head of the section of male infertility.
Peter R. Carroll, MD, has been appointed director of clinical services and strategic planning of the University of California, San Francisco Comprehensive Cancer Center and associate dean of the UCSF School of Medicine.
Vardenafil (Levitra) appears to be effective at first dose, with continued success in treating erectile dysfunction in men with associated medical conditions, including hypertension, diabetes, and dyslipidemia, the authors of a Canadian study report.
Treatment with anti-thymocyte globulin (rabbit [Thymoglobulin]) results in a significantly reduced risk of acute rejection and acute rejection requiring antibody therapy and a similar risk of delayed graft function, graft loss, and death in kidney transplant patients compared with patients receiving induction therapy with basiliximab (Simulect), according to a study published this month in the New England Journal of Medicine (2006; 355:1967-77).
Topiramate (Topamax), a drug commonly prescribed to treat seizures and migraines, can increase the propensity for calcium phosphate kidney stones, according to a study by researchers at the University of Texas Southwestern Medical Center in Dallas.
A coalition of prostate cancer advocacy groups has issued a call for Medicare to drop its least costly alternative (LCA) policy of for prostate cancer patients.
Men with overactive bladder and lower urinary tract symptoms who receive combination therapy are more likely to report improvement in symptoms than those who receive only one medication, according to results of a study recently reported in JAMA (2006; 296:2319-28).
PSA velocity is an accurate gauge of prostate tumor aggression and danger, even when PSA levels are so low as to not warrant a biopsy, according to researchers at the Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore.
Diagnostic Ultrasound Corp. has updated its company name to Verathon, Inc. (Bothell, WA).
Timm Medical said the FDA has allowed the company to extend the labeling of its Osbon ErecAid device for use in creating and maintaining erections by providing arterial blood to the penis during recovery from radical prostatectomy.
Firefighters in five Rhode Island communities are being offered free screening for bladder cancer in a voluntary program paid for and sponsored by their local state representatives.
Two consumer advocacy groups have joined with the Surgical Care Improvement Project (SCIP) to improve patient safety during surgery and increase communication between patients and their caregivers.
New guidelines, one set for adults and one for children, have been developed to help physicians reduce the occurrence of postoperative nausea and vomiting.
New explanatory analyses of a phase III study support earlier results observed with treatment using the investigational active cellular immunotherapy sipuleucel-T (Provenge) in men with advanced androgen-independent prostate cancer, researchers reported at the Prostate Cancer Foundation's annual scientific retreat in Scottsdale, AZ.
The National Cancer Institute has released new data from the Cancer Genetic Markers of Susceptibility study on prostate cancer that may help identify genetic factors that influence the disease and will be integral to the discovery and development of new targeted therapies.
It's easy to spot the complainer, but that is the exception.
Cleveland-Intravenous ketorolac tromethamine is safe and appears to be effective at alleviating pain following percutaneous nephrolithotomy (PNL) procedures in properly selected patients, according to a study from the Methodist Hospital Institute for Kidney Stone Disease and Indiana University School of Medicine, Indianapolis.
An increase in 2007 of $190 million was requested to promote program integration and interdisciplinary team science.
Cherry Hill, NJ-Lightweight Clip Mags from Vision USA attach to eyeglasses or safety glasses with non-scratch coated clips. Whether in bifocal or full-field magnification, they are available in strengths of 1.0?, 1.5?, 2.0?, 2.5?, 3.0?, 3.5?< and 4.0? power. When not in use, they flip up out of the way.
It's easy to spot the complainer, but that is the exception.
What is considered the usual postoperative bleeding time following a transurethral resection of the prostate?
Between 30% and 60% of calcium oxalate stone patients have hypercalciuria in the absence of raised serum calcium levels.